Edition:
United Kingdom

Genetic Technologies Ltd (GENE.OQ)

GENE.OQ on NASDAQ Stock Exchange Capital Market

0.90USD
15 Dec 2017
Change (% chg)

$-0.01 (-1.09%)
Prev Close
$0.91
Open
$0.90
Day's High
$0.97
Day's Low
$0.90
Volume
9,740
Avg. Vol
28,854
52-wk High
$1.38
52-wk Low
$0.70

Chart for

About

Genetic Technologies Limited is a molecular diagnostics company. The Company is engaged in the provision of molecular risk assessment for cancer. The Company offers predictive testing and assessment tools for physicians to manage women's health. The Company's lead product, BREVAGenplus, is a clinically validated risk assessment... (more)
No analyst recommendations are available for .

Overall

Beta: 2.64
Market Cap(Mil.): $15.14
Shares Outstanding(Mil.): 16.24
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 88.66 16.44
EPS (TTM): -- -- --
ROI: -- 2.36 10.62
ROE: -- 2.96 14.20

BRIEF-Genetic Technologies Provides Update On Strategic Review Initiative

* GENETIC TECHNOLOGIES PROVIDES UPDATE ON STRATEGIC REVIEW INITIATIVE

12 Dec 2017

BRIEF-Genetic Technologies announces comprehensive review of strategic alternatives

* Genetic Technologies announces comprehensive review of strategic alternatives

25 Aug 2017

Competitors

  Price Chg
Sonic Healthcare Limited (SHL.AX) $23.08 +0.13
Healthscope Ltd (HSO.AX) $2.05 +0.05

Earnings vs. Estimates